Róbert Halmosi
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
-
- Heart Failure Treatment and Management
- Cardiac Fibrosis and Remodeling
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Cardiac Fibrosis and Remodeling 7
- Heart Failure Treatment and Management 6
- Renin-Angiotensin System Studies 3
-
- Sirtuins and Resveratrol in Medicine 5
- Co-authors
- Kálmán Tóth (38 shared papers)Balázs Sümegi (19 shared papers)Eszter Szabados (7 shared papers)László Deres (19 shared papers)László Czopf (11 shared papers)Klara Magyar (7 shared papers)Tamás Habon (12 shared papers)Anita Pálfi (5 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (5 papers)PLoS ONE (4 papers)European Heart Journal (3 papers)International Journal of Cardiology (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- HungaryUnited StatesCroatia
In The Last Decade
Róbert Halmosi
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Geriatrics and Gerontology 318
- Cardiology and Cardiovascular Medicine 417
- Biochemistry 115
- Aging 18
- Drug Discovery 3
Countries citing papers authored by Róbert Halmosi
This map shows the geographic impact of Róbert Halmosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Halmosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Halmosi more than expected).
Fields of papers citing papers by Róbert Halmosi
This network shows the impact of papers produced by Róbert Halmosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Halmosi. The network helps show where Róbert Halmosi may publish in the future.
Co-authors
The 25 scholars most cited alongside Róbert Halmosi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 326 | |
| 2 | 2018 | 129 | |
| 3 | 2001 | 124 | |
| 4 | 2017 | 110 | |
| 5 | 2021 | 93 | |
| 6 | 2002 | 85 | |
| 7 | 2009 | 61 | |
| 8 | 2004 | 54 | |
| 9 | 2020 | 48 | |
| 10 | 2017 | 47 | |
| 11 | 2005 | 44 | |
| 12 | 2021 | 38 | |
| 13 | 2003 | 37 | |
| 14 | 2014 | 35 | |
| 15 | 2023 | 35 | |
| 16 | 2021 | 32 | |
| 17 | 2020 | 28 | |
| 18 | 2001 | 27 | |
| 19 | 2008 | 25 | |
| 20 | 2011 | 25 |
About Róbert Halmosi
Róbert Halmosi is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Biochemistry, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (7 papers), Heart Failure Treatment and Management (6 papers), Cardiac Ischemia and Reperfusion (5 papers), Sirtuins and Resveratrol in Medicine (5 papers), Blood properties and coagulation (4 papers), Mitochondrial Function and Pathology (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Renin-Angiotensin System Studies (3 papers). The work is most often cited by research in Geriatrics and Gerontology (318 citations), Cardiology and Cardiovascular Medicine (417 citations), Biochemistry (115 citations), Aging (18 citations) and Drug Discovery (3 citations). Róbert Halmosi has collaborated with scholars based in Hungary, United States and Croatia. Frequent co-authors include Kálmán Tóth, Balázs Sümegi, Eszter Szabados, László Deres, László Czopf, Klara Magyar, Tamás Habon, Anita Pálfi, Kálmán Hideg and Gergely Fehér. Their work appears in journals such as Journal of Cardiovascular Pharmacology, PLoS ONE, European Heart Journal, International Journal of Cardiology and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.